MALESCI, ALBERTO
MALESCI, ALBERTO
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Heterogeneity of colorectal cancer progression : Molecular gas and brakes
2021 F. Gaiani, F. Marchesi, F. Negri, L. Greco, A. Malesci, G.L. De'angelis, L. Laghi
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression
2019 T. Cavalleri, P. Bianchi, G. Basso, G. Celesti, F. Grizzi, P. Bossi, L. Greco, C. Pitrone, E. Valtorta, G. Mauri, M. Truini, F.G. Dall'Olio, G. Brandi, A. Sartore-Bianchi, L. Ricciardiello, V. Torri, L. Rimassa, S. Siena, A. Mantovani, A. Malesci, L. Laghi
Evolving notions on immune response in colorectal cancer and their implications for biomarker development
2018 F. Grizzi, G. Basso, E.M. Borroni, T. Cavalleri, P. Bianchi, S. Stifter, M. Chiriva-Internati, A. Malesci, L. Laghi
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice
2017 F. Ungaro, C. Tacconi, L. Massimino, P. Corsetto, C. Correale, P. Fonteyne, A. Piontini, V. Garzarelli, F. Calcaterra, S. Della Bella, A. Spinelli, M. Carvello, A. Rizzo, S. Vetrano, L. Petti, G. Fiorino, F. Furfaro, D. Mavilio, K. Maddipati, A. Malesci, L. Peyrin-Biroulet, S. D’Alessio, S. Danese
MFSD2A promotes epoxygenation of docosahexaenoic acid in gut endothelium to generate pro-resolving lipid mediators and dampen intestinal inflammation
2017 F. Ungaro, C. Tacconi, L. Massimino, P. Corsetto, C. Correale, P. Fonteyne, A. Piontini, V. Garzarelli, F. Calcaterra, S. Della Bella, A. Spinelli, M. Carvello, A. Rizzo, S. Vetrano, L. Petti, G. Fiorino, F. Furfaro, D. Mavilio, K. Maddipati, A. Malesci, S. D’Alessio, S. Danese
Tumor-associated macrophages and response to 5-flourouracil adjuvant therapy in stage III colorectal cancer
2017 A. Malesci, P. Bianchi, G. Celesti, G. Basso, F. Marchesi, F. Grizzi, G. DI CARO, T. Cavalleri, L. Rimassa, R. Palmqvist, A. Lugli, V..H. Koelzer, M. Roncalli, A. Mantovani, S. Ogino, L. Laghi
Tumour-associated macrophages as treatment targets in oncology
2017 A. Mantovani, F. Marchesi, A. Malesci, L. Laghi, P. Allavena
Hereditary or sporadic polyposis syndromes
2017 G. Basso, P. Bianchi, A. Malesci, L. Laghi
Treatment with a Urokinase Receptor-derived Cyclized Protein Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization
2016 M. Genua, V. Ingangi, P. Fonteyne, A. Piontini, A.M. Yousif, F. Merlino, P. Grieco, A. Malesci, M.V. Carriero, S. Danese
Effect of tumour necrosis factor antagonists on avoiding surgery in stricturing Crohn's disease: a tertiary centre real-life experience
2016 M. Allocca, G. Fiorino, C. Bonifacio, A. Spinelli, A. Repici, A. Malesci, L. Balzarini, S. Danese
Calcium supplementation for the prevention of colorectal adenomas : A systematic review and meta-analysis of randomized controlled trials
2016 S. Bonovas, G. Fiorino, T. Lytras, A. Malesci, S. Danese
KRAS mutation in lung metastases from colorectal cancer : Prognostic implications
2016 M. Ghidini, N. Personeni, S. Bozzarelli, M. Baretti, G. Basso, P. Bianchi, M.C. Tronconi, T. Pressiani, F. Grizzi, L. Giordano, A. Malesci, M. Alloisio, L. Laghi, A. Santoro, L. Rimassa
Occurrence and significance of tumor - Associated neutrophils in patients with colorectal cancer
2016 M.R. Galdiero, P. Bianchi, F. Grizzi, G. Di Caro, G. Basso, A. Ponzetta, E. Bonavita, M. Barbagallo, S. Tartari, N. Polentarutti, A. Malesci, G. Marone, M. Roncalli, L. Laghi, C. Garlanda, A. Mantovani, S. Jaillon
Autonomic nervous system dysregulation in irritable bowel syndrome
2015 B. Salvioli, G. Pellegatta, M. Malacarne, F. Pace, A. Malesci, M. Pagani, D. Lucini
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease
2015 G. Fiorino, C. Bonifacio, M. Allocca, A. Repici, L. Balzarini, A. Malesci, L. Peyrin Biroulet, S. Danese
Effect of Oral Administration of Methylene Blue MMx® Tablets on Double-Stranded DNA Damage Assessed by γH2AX Analysis of Colon Biopsy Samples- A Single Center, Open Label, Safety, Phase II Study
2015 A. Repici, M. Gerloni, C. Rosette, C. Ciscato, M. Wallace, A. Malesci, P. Sharma, S. Danese, R. Kiesslich
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation
2015 M. Genua, S. D'Alessio, J. Cibella, A. Gandelli, E. Sala, C. Correale, A. Spinelli, V. Arena, A. Malesci, S. Rutella, V.A. Ploplis, S. Vetrano, S. Danese
Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia
2014 A. Malesci, G. Basso, P. Bianchi, L. Fini, F. Grizzi, G. Celesti, G. Di Caro, G. Delconte, F. Dattola, A. Repici, M. Roncalli, M. Montorsi, L. Laghi
Preoperative magnetic resonance enterography in predicting findings and optimizing surgical approach in Crohn's disease
2014 A. Spinelli, G. Fiorino, P. Bazzi, M. Sacchi, C. Bonifacio, S. De Bastiani, A. Malesci, L. Balzarini, L. Peyrin Biroulet, M. Montorsi, S. Danese
Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers
2014 G. Di Caro, F. Bergomas, F. Grizzi, A. Doni, P. Bianchi, A. Malesci, L. Laghi, P. Allavena, A. Mantovani, F. Marchesi